NO971196D0 - Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid - Google Patents

Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid

Info

Publication number
NO971196D0
NO971196D0 NO971196A NO971196A NO971196D0 NO 971196 D0 NO971196 D0 NO 971196D0 NO 971196 A NO971196 A NO 971196A NO 971196 A NO971196 A NO 971196A NO 971196 D0 NO971196 D0 NO 971196D0
Authority
NO
Norway
Prior art keywords
androst
phenylprop
epimers
aza
carboxamide
Prior art date
Application number
NO971196A
Other languages
English (en)
Norwegian (no)
Other versions
NO971196L (no
Inventor
Achille Panzeri
Marcella Nesi
Enrico Di Salle
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO971196L publication Critical patent/NO971196L/no
Publication of NO971196D0 publication Critical patent/NO971196D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO971196A 1995-07-21 1997-03-14 Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid NO971196D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI001587A IT1275594B1 (it) 1995-07-21 1995-07-21 Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide
PCT/EP1996/002830 WO1997004002A1 (en) 1995-07-21 1996-06-28 EPIMERS OF (22RS)-N-(1,1,1-TRIFLUORO-2-PHENYLPROP-2-YL)-3-OXO-4-AZA-5α-ANDROST-1-ENE-17β-CARBOXAMIDE

Publications (2)

Publication Number Publication Date
NO971196L NO971196L (no) 1997-03-14
NO971196D0 true NO971196D0 (no) 1997-03-14

Family

ID=11372032

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971196A NO971196D0 (no) 1995-07-21 1997-03-14 Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid

Country Status (17)

Country Link
EP (1) EP0782582A1 (ko)
JP (1) JPH10506411A (ko)
KR (1) KR970706298A (ko)
CN (1) CN1159195A (ko)
AR (1) AR003967A1 (ko)
AU (1) AU6418396A (ko)
BR (1) BR9606527A (ko)
CA (1) CA2199273A1 (ko)
EA (1) EA199700045A1 (ko)
HU (1) HUP9702465A3 (ko)
IL (1) IL120343A0 (ko)
IT (1) IT1275594B1 (ko)
MX (1) MX9701948A (ko)
NO (1) NO971196D0 (ko)
PL (1) PL319351A1 (ko)
WO (1) WO1997004002A1 (ko)
ZA (1) ZA965678B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6137399A (en) * 1998-09-09 2000-03-27 Merck & Co., Inc. Method of determining and reducing the risk of bph-related urologic events
JP2002535274A (ja) * 1999-01-25 2002-10-22 スミスクライン・ビーチャム・コーポレイション 抗アンドロゲン剤および疾病の治療方法
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α－还原酶抑制活性的甾体化合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives

Also Published As

Publication number Publication date
NO971196L (no) 1997-03-14
IL120343A0 (en) 1997-06-10
CA2199273A1 (en) 1997-02-06
WO1997004002A1 (en) 1997-02-06
KR970706298A (ko) 1997-11-03
HUP9702465A2 (hu) 1998-05-28
ITMI951587A0 (it) 1995-07-21
PL319351A1 (en) 1997-08-04
EP0782582A1 (en) 1997-07-09
EA199700045A1 (ru) 1997-12-30
IT1275594B1 (it) 1997-08-06
ZA965678B (en) 1997-01-24
ITMI951587A1 (it) 1997-01-21
AR003967A1 (es) 1998-09-30
BR9606527A (pt) 1997-12-23
JPH10506411A (ja) 1998-06-23
AU6418396A (en) 1997-02-18
CN1159195A (zh) 1997-09-10
HUP9702465A3 (en) 1998-11-30
MX9701948A (es) 1997-06-28

Similar Documents

Publication Publication Date Title
NO970153L (no) Fremgangsmåte for syntese av substituerte sulfoksider
NO305833B1 (no) Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene
FI934971A0 (fi) Anlaeggning foer foerbraenning av spraengaemnen
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
DE69609199D1 (de) Lacton derivate von 17.beta.-carboxy, carbothio und amide androstanverbindungen
NO20005187D0 (no) n-sats syntese av 2-oksazolidinonderivater
NO982043D0 (no) Sammensetning av polyisocyanat
FI960425A (fi) Fenyylisykloheksyylikarboksyylihappoamidien käyttö
HK1017684A1 (en) Novel substituted 4-(1h-benzimidazol-2-yl)(1,4)diazepanes useful for the treatment of allergic diseases
NO960699D0 (no) Antimigren 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner
NO971196D0 (no) Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5&lt;alfa&gt;-androst-1-en-17&lt;beta&gt;-karboksamid
NO963187D0 (no) Fremgangsmåte for syntese av gamma-pyroner
ITTO930806A0 (it) Purificazione dell&#39; 1,1-dicloro-1-fluoroetano.
FI960957A0 (fi) Stabiloidun isotiatsolonin vesipitoisia seoksia
FI953319A0 (fi) Dimetyylinaftaleenin valmistus
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
KR960022630U (ko) 용광로의 풍구
KR970702873A (ko) 17β-시아노-3-에톡시-17α-하이드록시-6-메틸안드로스타-3,5,9-트리엔의 합성 방법(SYNTHESIS OF 17β-CYANO-3-ETHOXY-17α-HYDROXY-6-METHYLANDROSTA-3,5,9-TRIENE)
FR2711317B3 (fr) Nouvelle composition d&#39;une couche-culotte.
PT761766E (pt) Compostos assimetricos de trifenilenodioxazina
SI0874843T1 (en) Substituted 4-(1h-benzimidazol-2-yl) 1,4)diazepanes useful for the treatment of allergic diseases
LV5046A3 (lv) 3-(2,2,2-trimetilhidrazinij)propionata dihidrata iegusanas panemiens
FI930088A0 (fi) Urinsamlare foer underlaettande av provtagning fraon barn
KR970011853U (ko) 새로운 형태의 메리야스
ZA9610602B (en) Novel substituted 4-(1H-benzimidazol-2-yl)¬1,4¾diazepanes useful for the treatment of allergic diseases